Purpose: Laser photocoagulation is widely used to treat peripheral retinal pathologies. This study aims to investigate its impact on the macula and identify associated risk factors.
Methods: This prospective observational study enrolled patients undergoing laser photocoagulation for peripheral retinal degeneration and/or breaks were enrolled. Ocular examinations, including optical coherence tomography (OCT), OCT angiography (OCTA), and multifocal electroretinography (mf-ERG), were conducted at baseline and at 1- and 3-month post-treatment. Data were analyzed using paired t-tests and Pearson's correlation.
Results: Thirty-four eyes from 34 patients were included. The foveal avascular zone area significantly enlarged (Δ = 0.21 ± 0.35mm2, p = 0.038), and mf-ERG implicit times in perifoveal regions were prolonged (R3: Δ = 0.45 ± 0.70 ms, p = 0.027; R5: Δ = 0.85 ± 0.72 ms, p < 0.001) at 1 month following laser photocoagulation, with both parameters returning to baseline by 3 months. Laser photocoagulation also increased thickness in the parafoveal retinal nerve fiber layer (Δ = 1.72 ± 3.33 μm, p = 0.049), inner nuclear layer (Δ = 0.90 ± 1.35 μm, p = 0.014), and full-thickness foveal retina (Δ = 11.2 ± 21.1 μm, p = 0.043), with changes persisting up to 3 months (Δ = 2.74 ± 2.52 μm, p = 0.011; Δ = 0.79 ± 0.79 μm, p = 0.017; Δ = 8.51 ± 8.19 μm, p = 0.014, respectively). Correlation analysis revealed that both the number of laser spots and total laser energy were positively correlated with macular thickness, while the minimum distance between the laser and the fovea was negatively correlated with macular changes.
Conclusions: Peripheral retinal laser photocoagulation can induce foveal hypoperfusion, macular thickening, and prolonged implicit times. Although most of these changes are generally mild and reversible, macular thickening persisted throughout the 3-month follow-up period. Laser parameters, including the number of spots, energy, and distance from the fovea, are associated with macular changes.
目的:激光光凝术广泛应用于视网膜周围病变的治疗。本研究旨在探讨其对黄斑的影响,并确定相关的危险因素。方法:这项前瞻性观察研究纳入了接受激光光凝治疗周围视网膜变性和/或破裂的患者。在基线和治疗后1个月和3个月进行眼部检查,包括光学相干断层扫描(OCT)、OCT血管造影(OCTA)和多焦视网膜电图(mf-ERG)。数据分析采用配对t检验和Pearson相关。结果:纳入34例患者34只眼。视网膜中央凹无血管区面积明显扩大(Δ= 0.21±0.35平方毫米,p = 0.038),和mf-ERG perifoveal地区隐式时间延长(R3:女士Δ= 0.45±0.70,p = 0.027; R5:Δ= 0.85±0.72毫秒,p p = 0.049),内部核层(Δ= 0.90±1.35μm, p = 0.014),和全层视网膜中央凹视网膜(Δ= 11.2±21.1μm, p = 0.043),坚持3个月变化(Δ= 2.74±2.52μm, p = 0.011;Δ= 0.79±0.79μm, p = 0.017;Δ= 8.51±8.19μm, p = 0.014)。相关分析显示,激光光斑数和总激光能量与黄斑厚度呈正相关,而激光距中央凹最小距离与黄斑变化呈负相关。结论:外周视网膜激光光凝可引起视网膜中央凹灌注不足、黄斑增厚、内隐时间延长。虽然这些变化通常是轻微和可逆的,但黄斑增厚在3个月的随访期间持续存在。激光参数,包括斑点的数量,能量和距离中央凹,与黄斑的变化有关。
{"title":"Impact of Laser Photocoagulation for Peripheral Retinal Degeneration and Breaks on Macular Structure and Function.","authors":"Yingjia Lin, Biyao Xie, Chiyu Lin, Xuna Qiu, Weiqi Chen, Dinguo Huang, Zijing Huang","doi":"10.1080/02713683.2025.2611843","DOIUrl":"https://doi.org/10.1080/02713683.2025.2611843","url":null,"abstract":"<p><strong>Purpose: </strong>Laser photocoagulation is widely used to treat peripheral retinal pathologies. This study aims to investigate its impact on the macula and identify associated risk factors.</p><p><strong>Methods: </strong>This prospective observational study enrolled patients undergoing laser photocoagulation for peripheral retinal degeneration and/or breaks were enrolled. Ocular examinations, including optical coherence tomography (OCT), OCT angiography (OCTA), and multifocal electroretinography (mf-ERG), were conducted at baseline and at 1- and 3-month post-treatment. Data were analyzed using paired t-tests and Pearson's correlation.</p><p><strong>Results: </strong>Thirty-four eyes from 34 patients were included. The foveal avascular zone area significantly enlarged (Δ = 0.21 ± 0.35mm<sup>2</sup>, <i>p</i> = 0.038), and mf-ERG implicit times in perifoveal regions were prolonged (R3: Δ = 0.45 ± 0.70 ms, <i>p</i> = 0.027; R5: Δ = 0.85 ± 0.72 ms, <i>p</i> < 0.001) at 1 month following laser photocoagulation, with both parameters returning to baseline by 3 months. Laser photocoagulation also increased thickness in the parafoveal retinal nerve fiber layer (Δ = 1.72 ± 3.33 μm, <i>p</i> = 0.049), inner nuclear layer (Δ = 0.90 ± 1.35 μm, <i>p</i> = 0.014), and full-thickness foveal retina (Δ = 11.2 ± 21.1 μm, <i>p</i> = 0.043), with changes persisting up to 3 months (Δ = 2.74 ± 2.52 μm, <i>p</i> = 0.011; Δ = 0.79 ± 0.79 μm, <i>p</i> = 0.017; Δ = 8.51 ± 8.19 μm, <i>p</i> = 0.014, respectively). Correlation analysis revealed that both the number of laser spots and total laser energy were positively correlated with macular thickness, while the minimum distance between the laser and the fovea was negatively correlated with macular changes.</p><p><strong>Conclusions: </strong>Peripheral retinal laser photocoagulation can induce foveal hypoperfusion, macular thickening, and prolonged implicit times. Although most of these changes are generally mild and reversible, macular thickening persisted throughout the 3-month follow-up period. Laser parameters, including the number of spots, energy, and distance from the fovea, are associated with macular changes.</p>","PeriodicalId":10782,"journal":{"name":"Current Eye Research","volume":" ","pages":"1-10"},"PeriodicalIF":2.0,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145984618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-14DOI: 10.1080/02713683.2026.2613441
Jie Wang, Lingling Ba, Jiantao Ren, Rong Luan, Shuaixin Lu, Kai Wen, Jing Sun
Purpose: This study aimed to provide direct evidence of the potential role of N6-methyladenosine (m6A) modification in the progression of myopia. We focused on identifying genes that may be involved in scleral remodeling through m6A regulation in myopia.
Methods: We utilized m6A methylation immunoprecipitation sequencing (MeRIP-seq) alongside RNA sequencing (RNA-seq) to investigate the levels of m6A modification and mRNA expression in the scleras of form-deprived myopic (FDM) guinea pigs. Subsequent bioinformatics analysis was performed to identify the enriched pathways and genes associated with m6A modification.
Results: Bioinformatic analyses indicated that hypermethylated mRNAs were predominantly associated with the calcium signaling pathway and may participate in extracellular matrix (ECM) remodeling. Through integrated analysis of MeRIP-seq and RNA-seq data, it was found that more than half of the differentially expressed modified genes (DEGs) exhibiting increased mRNA levels also showed an upregulation of m6A modification levels. These genes may play significant roles in the process of myopic scleral remodeling in response to elevated levels of methyltransferase METTL14.
Conclusion: This study highlights the role of m6A methylation, mediated by METTL14, in the regulating of key genes involved in calcium signaling and ECM remodeling during myopia progression. These findings suggest that targeting m6A modifications may could offer new therapeutic strategies for the treatment of myopia.
{"title":"Alterations in N6-Methyladenosine (m<sup>6</sup>A) Modification of mRNA in the Sclera of Form-Deprived Myopic Guinea Pig.","authors":"Jie Wang, Lingling Ba, Jiantao Ren, Rong Luan, Shuaixin Lu, Kai Wen, Jing Sun","doi":"10.1080/02713683.2026.2613441","DOIUrl":"https://doi.org/10.1080/02713683.2026.2613441","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to provide direct evidence of the potential role of N6-methyladenosine (m<sup>6</sup>A) modification in the progression of myopia. We focused on identifying genes that may be involved in scleral remodeling through m<sup>6</sup>A regulation in myopia.</p><p><strong>Methods: </strong>We utilized m<sup>6</sup>A methylation immunoprecipitation sequencing (MeRIP-seq) alongside RNA sequencing (RNA-seq) to investigate the levels of m<sup>6</sup>A modification and mRNA expression in the scleras of form-deprived myopic (FDM) guinea pigs. Subsequent bioinformatics analysis was performed to identify the enriched pathways and genes associated with m<sup>6</sup>A modification.</p><p><strong>Results: </strong>Bioinformatic analyses indicated that hypermethylated mRNAs were predominantly associated with the calcium signaling pathway and may participate in extracellular matrix (ECM) remodeling. Through integrated analysis of MeRIP-seq and RNA-seq data, it was found that more than half of the differentially expressed modified genes (DEGs) exhibiting increased mRNA levels also showed an upregulation of m<sup>6</sup>A modification levels. These genes may play significant roles in the process of myopic scleral remodeling in response to elevated levels of methyltransferase METTL14.</p><p><strong>Conclusion: </strong>This study highlights the role of m<sup>6</sup>A methylation, mediated by METTL14, in the regulating of key genes involved in calcium signaling and ECM remodeling during myopia progression. These findings suggest that targeting m<sup>6</sup>A modifications may could offer new therapeutic strategies for the treatment of myopia.</p>","PeriodicalId":10782,"journal":{"name":"Current Eye Research","volume":" ","pages":"1-12"},"PeriodicalIF":2.0,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145970673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-13DOI: 10.1080/02713683.2026.2615658
Huihang Wang, Yihua Zhu
Purpose: To explore the protective effect and underlying mechanism of exogenous αA-crystallin (CRYAA), a molecular chaperone with antioxidant properties, in retinal ischemia-reperfusion (I/R) injury via modulation of the Nrf2/HO-1 signaling pathway.
Methods: In vivo, retinal I/R injury was induced in Sprague Dawley rats by transient intraocular pressure elevation, followed by intravitreal CRYAA administration. In vitro, human retinal microvascular endothelial cells (HRMECs) were exposed to H2O2-induced oxidative stress with or without CRYAA treatment. Oxidative markers (ROS, MDA, SOD), apoptosis (TUNEL, Caspase-3), and Nrf2/HO-1 pathway activation were evaluated via histopathology, biochemical assays, Western blotting, and flow cytometry. Nrf2 overexpression and siRNA knockdown were performed to validate pathway involvement.
Results: CRYAA attenuated retinal edema and structural disorganization in I/R rats, restore partial retinal blood flow, reduced ROS (p < 0.05) and MDA levels, restored SOD activity (p < 0.05), and suppressed apoptosis by downregulating Caspase-3 (p < 0.05). Mechanistically, CRYAA enhanced Nrf2 phosphorylation, nuclear translocation, and HO-1 expression (p < 0.05). Nrf2 overexpression amplified these effects, while Nrf2 silencing abolished CRYAA's protection, confirming pathway dependency.
Conclusions: Exogenous CRYAA mitigates retinal I/R injury by activating the Nrf2/HO-1 axis, reducing oxidative stress, and inhibiting apoptosis. These findings highlight CRYAA's therapeutic potential for ischemic retinal disorders and underscore Nrf2 as a critical mediator of its protective effects.
目的:探讨外源性α a-晶体蛋白(CRYAA)通过调控Nrf2/HO-1信号通路对视网膜缺血再灌注(I/R)损伤的保护作用及其机制。方法:在体内通过短暂眼压升高诱导大鼠视网膜I/R损伤,然后玻璃体内给予CRYAA。在体外,人视网膜微血管内皮细胞(HRMECs)暴露于h2o2诱导的氧化应激下,有或没有CRYAA处理。通过组织病理学、生化分析、Western blotting和流式细胞术评估氧化标志物(ROS、MDA、SOD)、细胞凋亡(TUNEL、Caspase-3)和Nrf2/HO-1通路激活。通过Nrf2过表达和siRNA敲低来验证通路参与。结果:CRYAA可减轻I/R大鼠视网膜水肿和结构紊乱,恢复部分视网膜血流量,降低ROS (p p p p p)。结论:外源性CRYAA可通过激活Nrf2/HO-1轴、降低氧化应激、抑制细胞凋亡等途径减轻视网膜I/R损伤。这些发现强调了CRYAA对缺血性视网膜疾病的治疗潜力,并强调了Nrf2作为其保护作用的关键介质。
{"title":"αA-Crystallin Attenuates Retinal Ischemia-Reperfusion Injury.","authors":"Huihang Wang, Yihua Zhu","doi":"10.1080/02713683.2026.2615658","DOIUrl":"https://doi.org/10.1080/02713683.2026.2615658","url":null,"abstract":"<p><strong>Purpose: </strong>To explore the protective effect and underlying mechanism of exogenous αA-crystallin (CRYAA), a molecular chaperone with antioxidant properties, in retinal ischemia-reperfusion (I/R) injury <i>via</i> modulation of the Nrf2/HO-1 signaling pathway.</p><p><strong>Methods: </strong><i>In vivo</i>, retinal I/R injury was induced in Sprague Dawley rats by transient intraocular pressure elevation, followed by intravitreal CRYAA administration. <i>In vitro</i>, human retinal microvascular endothelial cells (HRMECs) were exposed to H<sub>2</sub>O<sub>2</sub>-induced oxidative stress with or without CRYAA treatment. Oxidative markers (ROS, MDA, SOD), apoptosis (TUNEL, Caspase-3), and Nrf2/HO-1 pathway activation were evaluated <i>via</i> histopathology, biochemical assays, Western blotting, and flow cytometry. Nrf2 overexpression and siRNA knockdown were performed to validate pathway involvement.</p><p><strong>Results: </strong>CRYAA attenuated retinal edema and structural disorganization in I/R rats, restore partial retinal blood flow, reduced ROS (<i>p</i> < 0.05) and MDA levels, restored SOD activity (<i>p</i> < 0.05), and suppressed apoptosis by downregulating Caspase-3 (<i>p</i> < 0.05). Mechanistically, CRYAA enhanced Nrf2 phosphorylation, nuclear translocation, and HO-1 expression (<i>p</i> < 0.05). Nrf2 overexpression amplified these effects, while Nrf2 silencing abolished CRYAA's protection, confirming pathway dependency.</p><p><strong>Conclusions: </strong>Exogenous CRYAA mitigates retinal I/R injury by activating the Nrf2/HO-1 axis, reducing oxidative stress, and inhibiting apoptosis. These findings highlight CRYAA's therapeutic potential for ischemic retinal disorders and underscore Nrf2 as a critical mediator of its protective effects.</p>","PeriodicalId":10782,"journal":{"name":"Current Eye Research","volume":" ","pages":"1-9"},"PeriodicalIF":2.0,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145965283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: The study aims to investigate the relationship between pancreatic β-cell function and macular vascular structure and blood flow in patients with type 2 diabetes mellitus (DM) without clinical signs of diabetic retinopathy (DR).
Methods: This prospective cross-sectional study enrolled 121 type 2 DM patients without clinical DR, representing a total of 240 eyes. The area under the C-peptide release curve (AUCC) derived from the oral glucose tolerance test, fasting serum C-peptide level and the updated Homeostasis Model Assessment (HOMA2) model were utilized to reflect pancreatic β-cell function. Insulin resistance (IR) was assessed by HOMA2 model. The macular vascular and blood flow parameters of patients were measured by optical coherence tomography angiography (OCTA). Separate Linear Mixed-Effects Models were employed to analyze the relationship between pancreatic β-cell function indicators and OCTA metrics.
Results: In separate multivariate models, AUCC, fasting serum C-peptide level, and HOMA2 estimates of β-cell function (HOMA2-B) each demonstrated a significant positive association with vessel density (VD) measures in the deep capillary plexus (DCP), including total DCP VD, parafoveal DCP VD, and perifoveal DCP VD.
Conclusions: The impaired pancreatic β-cell function is significantly associated with adverse macular vasculature alterations, suggesting that these vascular changes may occur prior to the clinical manifestation of DR in patients with compromised β-cell function. β-cell function markers might help identify patients at risk of early subclinical retinal microvascular changes.
{"title":"Association Between Pancreatic β-Cell Function and Quantitative OCT Angiography Metrics in Patients with Type 2 Diabetes Without Clinical Diabetic Retinopathy.","authors":"Hanmu Guo, Yicheng Lu, Jianqing Li, Mengping Wu, Yanhui Xiao, Yanjun Wan, Bimin Shi, Peirong Lu","doi":"10.1080/02713683.2026.2612760","DOIUrl":"https://doi.org/10.1080/02713683.2026.2612760","url":null,"abstract":"<p><strong>Purpose: </strong>The study aims to investigate the relationship between pancreatic β-cell function and macular vascular structure and blood flow in patients with type 2 diabetes mellitus (DM) without clinical signs of diabetic retinopathy (DR).</p><p><strong>Methods: </strong>This prospective cross-sectional study enrolled 121 type 2 DM patients without clinical DR, representing a total of 240 eyes. The area under the C-peptide release curve (AUCC) derived from the oral glucose tolerance test, fasting serum C-peptide level and the updated Homeostasis Model Assessment (HOMA2) model were utilized to reflect pancreatic β-cell function. Insulin resistance (IR) was assessed by HOMA2 model. The macular vascular and blood flow parameters of patients were measured by optical coherence tomography angiography (OCTA). Separate Linear Mixed-Effects Models were employed to analyze the relationship between pancreatic β-cell function indicators and OCTA metrics.</p><p><strong>Results: </strong>In separate multivariate models, AUCC, fasting serum C-peptide level, and HOMA2 estimates of β-cell function (HOMA2-B) each demonstrated a significant positive association with vessel density (VD) measures in the deep capillary plexus (DCP), including total DCP VD, parafoveal DCP VD, and perifoveal DCP VD.</p><p><strong>Conclusions: </strong>The impaired pancreatic β-cell function is significantly associated with adverse macular vasculature alterations, suggesting that these vascular changes may occur prior to the clinical manifestation of DR in patients with compromised β-cell function. β-cell function markers might help identify patients at risk of early subclinical retinal microvascular changes.</p>","PeriodicalId":10782,"journal":{"name":"Current Eye Research","volume":" ","pages":"1-9"},"PeriodicalIF":2.0,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145958824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: To investigate the causal relationship between age-related macular degeneration (AMD) and inflammatory bowel disease (IBD) by Mendelian randomization (MR) analysis.
Methods: The single nucleotide polymorphism data of IBD and AMD were obtained from the Integrative Epidemiology Unit (IEU) Open genome-wide association study database. MR analysis contained MR-Egger, weighted median, inverse variance weighted, simple mode, and weighted mode. Sensitivity analysis was executed to ensure the reliability of results, containing heterogeneity test, horizontal pleiotropy test, and leave-one-out analysis. Multivariable Mendelian randomization analysis was carried out to investigate potential confounding factors such as C-reactive protein, smoking, vitamin D deficiency. Genes corresponding to the instrumental variables (IVs) and functional enrichment analysis were executed.
Results: MR analysis showed a positive correlation between IBD and AMD (P < 0.05, OR > 1). Sensitivity analyses also did not reveal heterogeneity and horizontal pleiotropy. C-reactive protein, smoking, and vitamin D deficiency had no significant effect on AMD (P > 0.05). Genes corresponding to IVs were mainly associated with monocyte differentiation, cytokine receptor activity, etc., and act on signaling pathways such as Th17 cell differentiation, and there was a complex network of molecular-cell regulation.
Conclusion: Our study explored and demonstrated the causal relationship between IBD and AMD through MR analysis, which provided an important reference and direction for future research and treatment related to AMD.
{"title":"Mendelian Randomization Study of Age-Related Macular Degeneration and Inflammatory Bowel Disease.","authors":"Zhijuan Hua, Qing Zhu, Jingfei Yang, Maodan Tang, Jie Yin, Dong Zhan","doi":"10.1080/02713683.2025.2602902","DOIUrl":"https://doi.org/10.1080/02713683.2025.2602902","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the causal relationship between age-related macular degeneration (AMD) and inflammatory bowel disease (IBD) by Mendelian randomization (MR) analysis.</p><p><strong>Methods: </strong>The single nucleotide polymorphism data of IBD and AMD were obtained from the Integrative Epidemiology Unit (IEU) Open genome-wide association study database. MR analysis contained MR-Egger, weighted median, inverse variance weighted, simple mode, and weighted mode. Sensitivity analysis was executed to ensure the reliability of results, containing heterogeneity test, horizontal pleiotropy test, and leave-one-out analysis. Multivariable Mendelian randomization analysis was carried out to investigate potential confounding factors such as C-reactive protein, smoking, vitamin D deficiency. Genes corresponding to the instrumental variables (IVs) and functional enrichment analysis were executed.</p><p><strong>Results: </strong>MR analysis showed a positive correlation between IBD and AMD (<i>P</i> < 0.05, OR > 1). Sensitivity analyses also did not reveal heterogeneity and horizontal pleiotropy. C-reactive protein, smoking, and vitamin D deficiency had no significant effect on AMD (<i>P</i> > 0.05). Genes corresponding to IVs were mainly associated with monocyte differentiation, cytokine receptor activity, etc., and act on signaling pathways such as Th17 cell differentiation, and there was a complex network of molecular-cell regulation.</p><p><strong>Conclusion: </strong>Our study explored and demonstrated the causal relationship between IBD and AMD through MR analysis, which provided an important reference and direction for future research and treatment related to AMD.</p>","PeriodicalId":10782,"journal":{"name":"Current Eye Research","volume":" ","pages":"1-9"},"PeriodicalIF":2.0,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145917241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-06DOI: 10.1080/02713683.2025.2606332
Bin Wang, Xudong Li
Purpose: Primary open-angle glaucoma is characterized by trabecular meshwork cell injury and excessive extracellular matrix deposition. Given the established involvement of long non-coding RNAs in primary open-angle glaucoma pathogenesis, this study investigates the role and mechanism of long non-coding RNA H19 in mediating trabecular meshwork cell dysfunction and extracellular matrix production.
Methods: Hydrogen peroxide-treated human trabecular meshwork cells were used to establish in vitro primary open-angle glaucoma models. Cell viability and apoptosis were assessed via cell counting kit-8 and flow cytometry. Gene/protein expression of H19, Smad4, and extracellular matrix components (fibronectin, collagen I, and laminin) was evaluated by real-time quantitative polymerase chain reaction, Western blotting, and immunofluorescence. Subcellular H19 localization was determined by nuclear-cytoplasmic fractionation. The H19-miR-20a-5p-Smad4 regulatory axis was validated through luciferase reporter assays and rescue experiments across three characterized human trabecular meshwork cell strains.
Results: Hydrogen peroxide exposure induced concentration-dependent human trabecular meshwork cell injury and significantly upregulated H19 and Smad4 expression (p < 0.001). H19 knockdown attenuated oxidative damage, restoring viability (p < 0.001), reducing apoptosis (p < 0.001), and suppressing extracellular matrix deposition (p < 0.001). Mechanistically, H19 functioned as a competing endogenous RNA by binding miR-20a-5p, which targeted Smad4. Smad4 overexpression or miR-20a-5p inhibition abrogated H19 deficiency-mediated protection. Notably, H19 knockdown also reduced transforming growth factor-beta/Smad signaling (p < 0.001) while enhancing nuclear factor erythroid 2-related factor 2/heme oxygenase-1 antioxidant responses (p < 0.001).
Conclusion: Long non-coding RNA H19 facilitates hydrogen peroxide-induced human trabecular meshwork cell injury and extracellular matrix deposition primarily by orchestrating the miR-20a-5p/Smad4 axis, with additional modulation of transforming growth factor-beta/Smad and nuclear factor erythroid 2-related factor 2 pathways.
目的:原发性开角型青光眼以小梁网细胞损伤和细胞外基质过度沉积为特征。考虑到长链非编码RNA在原发性开角型青光眼发病中的作用,本研究探讨了长链非编码RNA H19在调节小梁网细胞功能障碍和细胞外基质生成中的作用和机制。方法:采用过氧化氢处理的人小梁网细胞,建立离体原发性开角型青光眼模型。通过细胞计数试剂盒-8和流式细胞术检测细胞活力和凋亡情况。通过实时定量聚合酶链反应、Western blotting和免疫荧光检测H19、Smad4和细胞外基质成分(纤维连接蛋白、I型胶原和层粘连蛋白)的基因/蛋白表达。亚细胞H19定位通过核细胞质分离确定。H19-miR-20a-5p-Smad4调控轴通过荧光素酶报告基因检测和三种人类小梁网细胞株的拯救实验得到验证。结果:过氧化氢暴露诱导浓度依赖性人小梁网细胞损伤,显著上调H19和Smad4表达(p p p p p p p p p p)结论:长链非编码RNA H19主要通过协调miR-20a-5p/Smad4轴促进过氧化氢诱导的人小梁网细胞损伤和细胞外基质沉积,并额外调节转化生长因子- β /Smad和核因子红系2相关因子2通路。
{"title":"LncRNA H19 Promotes H<sub>2</sub>O<sub>2</sub>-Induced Human Trabecular Meshwork Cell Injury and Extracellular Matrix Production by Regulating the miR-20a-5p/Smad4 Axis.","authors":"Bin Wang, Xudong Li","doi":"10.1080/02713683.2025.2606332","DOIUrl":"https://doi.org/10.1080/02713683.2025.2606332","url":null,"abstract":"<p><strong>Purpose: </strong>Primary open-angle glaucoma is characterized by trabecular meshwork cell injury and excessive extracellular matrix deposition. Given the established involvement of long non-coding RNAs in primary open-angle glaucoma pathogenesis, this study investigates the role and mechanism of long non-coding RNA H19 in mediating trabecular meshwork cell dysfunction and extracellular matrix production.</p><p><strong>Methods: </strong>Hydrogen peroxide-treated human trabecular meshwork cells were used to establish <i>in vitro</i> primary open-angle glaucoma models. Cell viability and apoptosis were assessed via cell counting kit-8 and flow cytometry. Gene/protein expression of H19, Smad4, and extracellular matrix components (fibronectin, collagen I, and laminin) was evaluated by real-time quantitative polymerase chain reaction, Western blotting, and immunofluorescence. Subcellular H19 localization was determined by nuclear-cytoplasmic fractionation. The H19-miR-20a-5p-Smad4 regulatory axis was validated through luciferase reporter assays and rescue experiments across three characterized human trabecular meshwork cell strains.</p><p><strong>Results: </strong>Hydrogen peroxide exposure induced concentration-dependent human trabecular meshwork cell injury and significantly upregulated H19 and Smad4 expression (<i>p</i> < 0.001). H19 knockdown attenuated oxidative damage, restoring viability (<i>p</i> < 0.001), reducing apoptosis (<i>p</i> < 0.001), and suppressing extracellular matrix deposition (<i>p</i> < 0.001). Mechanistically, H19 functioned as a competing endogenous RNA by binding miR-20a-5p, which targeted Smad4. Smad4 overexpression or miR-20a-5p inhibition abrogated H19 deficiency-mediated protection. Notably, H19 knockdown also reduced transforming growth factor-beta/Smad signaling (<i>p</i> < 0.001) while enhancing nuclear factor erythroid 2-related factor 2/heme oxygenase-1 antioxidant responses (<i>p</i> < 0.001).</p><p><strong>Conclusion: </strong>Long non-coding RNA H19 facilitates hydrogen peroxide-induced human trabecular meshwork cell injury and extracellular matrix deposition primarily by orchestrating the miR-20a-5p/Smad4 axis, with additional modulation of transforming growth factor-beta/Smad and nuclear factor erythroid 2-related factor 2 pathways.</p>","PeriodicalId":10782,"journal":{"name":"Current Eye Research","volume":" ","pages":"1-12"},"PeriodicalIF":2.0,"publicationDate":"2026-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145910805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-05DOI: 10.1080/02713683.2025.2602167
Rumeysa Bilmez Tan, Serek Tekin, Zehra Akman İlik, Muhammed Batur, Erbil Seven, Meltem Tan Uygun
Purpose: To evaluate the therapeutic effects of bakuchiol on clinical and histopathological outcomes in a rat model of corneal alkali burn.
Methods: Corneal alkali burns were induced in the right eyes of 35 male Wistar rats, which were randomized into five groups: control, carbomer, steroid, 0.14 mg/g bakuchiol, and 0.28 mg/g bakuchiol. Examinations were performed under stereomicroscopy with intraperitoneal ketamine anesthesia on days 0, 3, 7, and 14 to assess corneal epithelial defects and opacity; on day 14, corneal neovascularization was additionally evaluated. After the final examination, the eyes were enucleated, and the corneas were processed for hematoxylin-eosin and immunohistochemical staining. Epithelial necrosis, inflammatory cell density, corneal hemorrhage, stromal edema, and staining intensity for VEGF and TNF-α were semi-quantitatively scored.
Results: Bakuchiol treatment, particularly at 0.28 mg/g, significantly reduced corneal opacity, neovascularization, hemorrhage, and stromal edema compared with the steroid-treated group.
Conclusions: Bakuchiol demonstrated promising anti-inflammatory and anti-angiogenic effects and may represent a potential adjunctive treatment for corneal chemical injuries.
{"title":"Efficacy of Bakuchiol in a Rat Model of Chemical Eye Injury.","authors":"Rumeysa Bilmez Tan, Serek Tekin, Zehra Akman İlik, Muhammed Batur, Erbil Seven, Meltem Tan Uygun","doi":"10.1080/02713683.2025.2602167","DOIUrl":"https://doi.org/10.1080/02713683.2025.2602167","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the therapeutic effects of bakuchiol on clinical and histopathological outcomes in a rat model of corneal alkali burn.</p><p><strong>Methods: </strong>Corneal alkali burns were induced in the right eyes of 35 male Wistar rats, which were randomized into five groups: control, carbomer, steroid, 0.14 mg/g bakuchiol, and 0.28 mg/g bakuchiol. Examinations were performed under stereomicroscopy with intraperitoneal ketamine anesthesia on days 0, 3, 7, and 14 to assess corneal epithelial defects and opacity; on day 14, corneal neovascularization was additionally evaluated. After the final examination, the eyes were enucleated, and the corneas were processed for hematoxylin-eosin and immunohistochemical staining. Epithelial necrosis, inflammatory cell density, corneal hemorrhage, stromal edema, and staining intensity for VEGF and TNF-α were semi-quantitatively scored.</p><p><strong>Results: </strong>Bakuchiol treatment, particularly at 0.28 mg/g, significantly reduced corneal opacity, neovascularization, hemorrhage, and stromal edema compared with the steroid-treated group.</p><p><strong>Conclusions: </strong>Bakuchiol demonstrated promising anti-inflammatory and anti-angiogenic effects and may represent a potential adjunctive treatment for corneal chemical injuries.</p>","PeriodicalId":10782,"journal":{"name":"Current Eye Research","volume":" ","pages":"1-11"},"PeriodicalIF":2.0,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145905834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-05DOI: 10.1080/02713683.2025.2592226
Timon Ax, Francesc March de Ribot, Fabian N Fries, Tomas L Bothe, Slade O Jensen, Thomas J Millar, Berthold Seitz
Purpose: When examining the ocular surface, patients are required to look straight ahead and the effects of vertical eye movement on tear film behavior are not considered despite it being natural and common to change gaze without blinking. This exposes parts of the bulbar conjunctiva previously covered by the eyelids and therefore not covered by the tear film during the preceding blink. This study investigates how the tear film behaves when presented with newly exposed areas of ocular surface due to vertical eye movements.
Methods: The tear film dynamics of a sequence of vertical open-eye gaze maneuvers (upgaze-downgaze) were studied in 15 participants with no ocular surface related complaints (OSDI <13) using the TearView infrared camera system. TearView detects the tear film based on natural infrared radiation emitted from the ocular surface. Interferometry was used to examine lipid layer behavior. In a subgroup (n = 3), eyelids were mechanically lifted using a finger to reveal bulbar conjunctiva.
Results: Vertical eye movements exposed bulbar conjunctiva not covered by the tear film during the preceding blink. The fully formed tear film reacted by spreading toward the newly uncovered ocular surface area, thereby recoating it. This also occurred when the eyelids were mechanically lifted to reveal ocular surface previously beneath the eyelids. No apparent flow occurred from the menisci onto the ocular surface.
Conclusions: The fully formed tear film is isolated from the meniscal tear and meibum reservoirs (a completely perched tear film). This tear film spontaneously spreads to cover ocular surface area that is newly exposed during vertical eye movements.
目的:在检查眼表时,要求患者直视前方,尽管不眨眼地变换目光是自然和常见的,但垂直眼运动对泪膜行为的影响并未考虑。这暴露了之前被眼睑覆盖的部分球结膜,因此在前一次眨眼时没有被泪膜覆盖。本研究探讨泪膜如何表现时,新暴露区域的眼表由于垂直眼运动。方法:对15例无眼表相关疾病(OSDI n = 3)的裸眼直视动作(上下凝视)的泪膜动态进行研究,用手指机械提起眼睑露出球结膜。结果:垂直眼动暴露前眨眼时未被泪膜覆盖的球结膜。完全形成的泪膜通过向新暴露的眼表区域扩散,从而重新覆盖它。当机械抬起眼睑,露出之前在眼皮下的眼表时,也会出现这种情况。从半月板到眼表没有明显的血流。结论:完整形成的撕裂膜与半月板撕裂和膜层分离(完全栖息的撕裂膜)。这种泪膜自发地扩散,覆盖在垂直眼球运动中新暴露的眼表区域。
{"title":"Lifting the Lid on Tear Film Dynamics: Tear Film Movement Upon Vertical Gaze Change.","authors":"Timon Ax, Francesc March de Ribot, Fabian N Fries, Tomas L Bothe, Slade O Jensen, Thomas J Millar, Berthold Seitz","doi":"10.1080/02713683.2025.2592226","DOIUrl":"https://doi.org/10.1080/02713683.2025.2592226","url":null,"abstract":"<p><strong>Purpose: </strong>When examining the ocular surface, patients are required to look straight ahead and the effects of vertical eye movement on tear film behavior are not considered despite it being natural and common to change gaze without blinking. This exposes parts of the bulbar conjunctiva previously covered by the eyelids and therefore not covered by the tear film during the preceding blink. This study investigates how the tear film behaves when presented with newly exposed areas of ocular surface due to vertical eye movements.</p><p><strong>Methods: </strong>The tear film dynamics of a sequence of vertical open-eye gaze maneuvers (upgaze-downgaze) were studied in 15 participants with no ocular surface related complaints (OSDI <13) using the TearView infrared camera system. TearView detects the tear film based on natural infrared radiation emitted from the ocular surface. Interferometry was used to examine lipid layer behavior. In a subgroup (<i>n</i> = 3), eyelids were mechanically lifted using a finger to reveal bulbar conjunctiva.</p><p><strong>Results: </strong>Vertical eye movements exposed bulbar conjunctiva not covered by the tear film during the preceding blink. The fully formed tear film reacted by spreading toward the newly uncovered ocular surface area, thereby recoating it. This also occurred when the eyelids were mechanically lifted to reveal ocular surface previously beneath the eyelids. No apparent flow occurred from the menisci onto the ocular surface.</p><p><strong>Conclusions: </strong>The fully formed tear film is isolated from the meniscal tear and meibum reservoirs (a completely perched tear film). This tear film spontaneously spreads to cover ocular surface area that is newly exposed during vertical eye movements.</p>","PeriodicalId":10782,"journal":{"name":"Current Eye Research","volume":" ","pages":"1-9"},"PeriodicalIF":2.0,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145905820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-04DOI: 10.1080/02713683.2025.2607477
Ronnie Mooney, Jamie Whitelaw, Stuart Woods, Fiona Henriquez
Purpose: Acanthamoeba keratitis (AK) is a sight threatening infection of the cornea caused by opportunistic pathogens belonging to the genus Acanthamoeba. AK is commonly associated with contact lens use, and treatments are currently limited and ineffective. As such, the emergence of antimicrobial resistance in Acanthamoeba poses a significant challenge to the management of AK. This study investigates the development of polyhexamethylene biguanide (PHMB) resistance, a frontline therapeutic, in Acanthamoeba trophozoites and explores potential cross-resistance to hexamidine and voriconazole.
Methods: Acanthamoeba castellanii trophozoites were exposed and maintained in PHMB starting at 2 µg/mL and increasing upon reaching confluence. Cells were subsequently exposed to incrementally higher doses of PHMB in a stepwise manner (2, 4, 5.5, and 7 µg/mL). When sustained growth under PHMB exposure was observed, morphology was assessed by imaging flow cytometry and susceptibility assays were performed by incubating resistant strains with PHMB, hexamidine, and voriconazole for 24 h, and viability determined using alamarBlue.
Results: Trophozoites surviving exposure at 2 µg/mL reached confluence within 11 days. Stepwise increases to 4 µg/mL, 5.5 µg/mL, and 7 µg/mL were achieved within 6-7 days at each stage. PHMB-resistant Acanthamoeba strains exhibited a 9-fold increase in resistance to PHMB relative to naïve cells, alongside significant cross-resistance to voriconazole (159-fold) and hexamidine (8.4-fold). No significant change in trophozoite or cyst morphology was observed relative to the naïve cell line.
Conclusions: These findings represent the first known laboratory-induced PHMB-resistant Acanthamoeba strains, raising concerns regarding the longevity of current therapeutic options and the potential for cross-resistance to alternative treatments. This highlights the need for clinical vigilance and further investigation into the molecular mechanisms of resistance to better inform treatment strategies.
{"title":"Emergence of PHMB Resistance in <i>Acanthamoeba castellanii</i> and Observations on Cross-Resistance to Other Frontline Therapeutics.","authors":"Ronnie Mooney, Jamie Whitelaw, Stuart Woods, Fiona Henriquez","doi":"10.1080/02713683.2025.2607477","DOIUrl":"https://doi.org/10.1080/02713683.2025.2607477","url":null,"abstract":"<p><strong>Purpose: </strong><i>Acanthamoeba</i> keratitis (AK) is a sight threatening infection of the cornea caused by opportunistic pathogens belonging to the genus <i>Acanthamoeba</i>. AK is commonly associated with contact lens use, and treatments are currently limited and ineffective. As such, the emergence of antimicrobial resistance in <i>Acanthamoeba</i> poses a significant challenge to the management of AK. This study investigates the development of polyhexamethylene biguanide (PHMB) resistance, a frontline therapeutic, in <i>Acanthamoeba</i> trophozoites and explores potential cross-resistance to hexamidine and voriconazole.</p><p><strong>Methods: </strong><i>Acanthamoeba castellanii</i> trophozoites were exposed and maintained in PHMB starting at 2 µg/mL and increasing upon reaching confluence. Cells were subsequently exposed to incrementally higher doses of PHMB in a stepwise manner (2, 4, 5.5, and 7 µg/mL). When sustained growth under PHMB exposure was observed, morphology was assessed by imaging flow cytometry and susceptibility assays were performed by incubating resistant strains with PHMB, hexamidine, and voriconazole for 24 h, and viability determined using alamarBlue.</p><p><strong>Results: </strong>Trophozoites surviving exposure at 2 µg/mL reached confluence within 11 days. Stepwise increases to 4 µg/mL, 5.5 µg/mL, and 7 µg/mL were achieved within 6-7 days at each stage. PHMB-resistant <i>Acanthamoeba</i> strains exhibited a 9-fold increase in resistance to PHMB relative to naïve cells, alongside significant cross-resistance to voriconazole (159-fold) and hexamidine (8.4-fold). No significant change in trophozoite or cyst morphology was observed relative to the naïve cell line.</p><p><strong>Conclusions: </strong>These findings represent the first known laboratory-induced PHMB-resistant <i>Acanthamoeba</i> strains, raising concerns regarding the longevity of current therapeutic options and the potential for cross-resistance to alternative treatments. This highlights the need for clinical vigilance and further investigation into the molecular mechanisms of resistance to better inform treatment strategies.</p>","PeriodicalId":10782,"journal":{"name":"Current Eye Research","volume":" ","pages":"1-5"},"PeriodicalIF":2.0,"publicationDate":"2026-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145899493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-25DOI: 10.1080/02713683.2025.2585338
Jialing Tang, Junjie Chen, Zhaohuai Li, Genxian Zhang, Lei Zhu, He Li, Wenru Su, Shuyan Qin
Purpose: This study aims to elucidate the causal relationships and shared genetic architecture between metabolic-associated diseases and risk factors-including hypertension, type 1 diabetes (T1D), type 2 diabetes (T2D), low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and body mass index (BMI)-and primary vision-threatening eye disorders, involving glaucoma, cataracts, refractive disorders, and age-related macular degeneration (AMD).
Methods: We analyzed genome-wide association study (GWAS) summary statistics from > 500 000 individuals of European ancestry in the FinnGen, UK Biobank, and MRC-IEU databases to ensure adequate sample size. Linkage disequilibrium score regression (LDSC) was applied to estimate genetic correlations, while two-sample Mendelian randomization (MR) was performed to assess causal effects. Furthermore, a bidirectional Mendelian Randomization was further conducted to examine the directionality of associations between hypertension and cataracts.
Results: This study was the first to reveal genetic correlations and causal effects of hypertension on cataracts, particularly senile cataracts. MR analysis provided evidence that hypertension is causally associated with an increased risk of cataracts, particularly senile cataract, whereas the reverse association was not supported. Additionally, LDL cholesterol was suggested as a protective factor for AMD, while HDL cholesterol was associated with an increased risk. The LDSC analysis also indicated a suggestive genetic correlation between T2D and both cataracts and glaucoma, but not for T1D.
Conclusion: This study provides comprehensive evidence of genetic correlations and potential causal relationships between metabolic-associated conditions and major eye diseases contributing to vision loss.
{"title":"Genetic Correlation and Mendelian Randomization Analyses Reveal Causal Links Between Metabolic-Associated Diseases or Risk Factors and Major Eye Diseases.","authors":"Jialing Tang, Junjie Chen, Zhaohuai Li, Genxian Zhang, Lei Zhu, He Li, Wenru Su, Shuyan Qin","doi":"10.1080/02713683.2025.2585338","DOIUrl":"https://doi.org/10.1080/02713683.2025.2585338","url":null,"abstract":"<p><strong>Purpose: </strong>This study aims to elucidate the causal relationships and shared genetic architecture between metabolic-associated diseases and risk factors-including hypertension, type 1 diabetes (T1D), type 2 diabetes (T2D), low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and body mass index (BMI)-and primary vision-threatening eye disorders, involving glaucoma, cataracts, refractive disorders, and age-related macular degeneration (AMD).</p><p><strong>Methods: </strong>We analyzed genome-wide association study (GWAS) summary statistics from > 500 000 individuals of European ancestry in the FinnGen, UK Biobank, and MRC-IEU databases to ensure adequate sample size. Linkage disequilibrium score regression (LDSC) was applied to estimate genetic correlations, while two-sample Mendelian randomization (MR) was performed to assess causal effects. Furthermore, a bidirectional Mendelian Randomization was further conducted to examine the directionality of associations between hypertension and cataracts.</p><p><strong>Results: </strong>This study was the first to reveal genetic correlations and causal effects of hypertension on cataracts, particularly senile cataracts. MR analysis provided evidence that hypertension is causally associated with an increased risk of cataracts, particularly senile cataract, whereas the reverse association was not supported. Additionally, LDL cholesterol was suggested as a protective factor for AMD, while HDL cholesterol was associated with an increased risk. The LDSC analysis also indicated a suggestive genetic correlation between T2D and both cataracts and glaucoma, but not for T1D.</p><p><strong>Conclusion: </strong>This study provides comprehensive evidence of genetic correlations and potential causal relationships between metabolic-associated conditions and major eye diseases contributing to vision loss.</p>","PeriodicalId":10782,"journal":{"name":"Current Eye Research","volume":" ","pages":"1-12"},"PeriodicalIF":2.0,"publicationDate":"2025-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145833185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}